A randomized controlled trial of low-dose Enoxaparin versus low-dose Edoxavan for prevention of venous thromboembolism after total hip arthroprasty in elderly or underweight or moderate renal insufficient patients.
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Edoxaban (Primary) ; Enoxaparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 04 Apr 2017 New trial record